This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...
A patient started on oral (PO) amiodarone approximately 1 week ago (400 mg/day). The patient is now taking nothing by mouth (NPO), and the physician would like to switch to intravenous (IV) amiodarone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results